Aptose Biosciences (NASDAQ:APTO) reported its Q4 earnings results on Tuesday, March 26, 2024 at 04:02 PM.
Here's what investors need to know about the announcement.
Earnings
Aptose Biosciences beat estimated earnings by 9.0%, reporting an EPS of $-1.44 versus an estimate of $-1.59.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.29 which was followed by a 24.0% drop in the share price the next day.
To track all earnings releases for Aptose Biosciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.